Cuba vs Madagascar: Previously treated cases tested for RR-/MDR-TB
Cuba
61.0%
in 2024
Madagascar
69.0%
in 2024
Cuba rank
136th
Madagascar rank
134th
Previously treated cases tested for RR-/MDR-TB over time
- Cuba
- Madagascar
How they compare
Madagascar currently reports 69.0% against 61.0% in Cuba, a difference of 8.0%.
That makes Madagascar's figure about 1.1 times Cuba's.
The two have swapped places 3 times across 19 shared years of data; in 2006 it was Cuba ahead.
Cuba ranks 136th and Madagascar ranks 134th of 180 countries.
Across the 3 decades both report, Cuba averaged higher in 2 and Madagascar in 1.
Head to head by decade
| Decade | Cuba | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.5% | 3.0% | 28.5% | Cuba |
| 2010s | 70.2% | 18.3% | 51.9% | Cuba |
| 2020s | 53.4% | 56.0% | 2.6% | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cuba or Madagascar?
- Madagascar, at 69.0% against 61.0% in Cuba as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cuba and Madagascar?
- 8.0%, with Madagascar ahead.
- How many years of comparable data are there for Cuba and Madagascar?
- 19 years are reported by both, from 2006 to 2024.
- How do Cuba and Madagascar rank globally for previously treated cases tested for rr-/mdr-tb?
- Cuba ranks 136th and Madagascar ranks 134th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.